- Q1 2024 Travere Therapeutics Inc Earnings Call TranscriptMay 06, 2024$6.55 (+4.63%)Earnings
- Q4 2023 Travere Therapeutics Inc Earnings Call TranscriptFeb 15, 2024$8.74 (+5.94%)Earnings
- Travere Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2024
- Q3 2023 Travere Therapeutics Inc Earnings Call TranscriptNov 07, 2023$7.18 (+8.13%)Earnings
- Travere Therapeutics Inc FILSPARI in IgA Nephropathy Phase 3 PROTECT Study Results Call TranscriptSep 21, 2023
- Q2 2023 Travere Therapeutics Inc Earnings Call TranscriptAug 03, 2023$16.28 (-2.05%)Earnings
- Mirum Pharmaceuticals Inc To Acquire Travere Therapeutics Inc Call TranscriptJul 17, 2023
- Travere Therapeutics Inc at Jefferies Healthcare Conference TranscriptJun 07, 2023
- Travere Therapeutics Inc at William Blair Growth Stock Conference TranscriptJun 06, 2023
- Travere Therapeutics Inc Pegtibatinase in Classical Homocystinuria Phase 1/2 COMPOSE Study Results Call TranscriptMay 31, 2023
- Travere Therapeutics Inc at Bank of America Global Healthcare Conference TranscriptMay 10, 2023
- Q1 2023 Travere Therapeutics Inc Earnings Call TranscriptMay 04, 2023$15.97 (+0.38%)Earnings
- Travere Therapeutics Inc Corporate Update Call TranscriptMay 01, 2023
- Travere Therapeutics Inc at Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days (Virtual) TranscriptApr 04, 2023
- Travere Therapeutics Inc at Barclays Global Healthcare Conference TranscriptMar 15, 2023
- Q4 2022 Travere Therapeutics Inc Earnings Call TranscriptFeb 23, 2023$21.88 (+4.84%)Earnings
- Travere Therapeutics Inc FDA Accelerated Approval of FILSPARI (Sparsentan) Call TranscriptFeb 17, 2023
- Travere Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 12, 2023
- Travere Therapeutics Inc at Bank of America Biotech SMID Cap Conference TranscriptDec 07, 2022
- Travere Therapeutics Inc at Piper Sandler Healthcare Conference TranscriptDec 01, 2022
- Travere Therapeutics Inc at Evercore ISI HealthCONx Conference (Virtual) TranscriptNov 29, 2022
- Q3 2022 Travere Therapeutics Inc Earnings Call TranscriptOct 27, 2022$22.48 (+1.08%)Earnings
- Travere Therapeutics Inc to Discuss the Regulatory Update Call TranscriptOct 13, 2022
- Q2 2022 Travere Therapeutics Inc Earnings Call TranscriptAug 04, 2022$25.79 (+7.46%)Earnings
- Travere Therapeutics Inc at Bank of America Healthcare Conference TranscriptMay 10, 2022
- Q1 2022 Travere Therapeutics Inc Earnings Call TranscriptMay 05, 2022$24.59 (-5.09%)Earnings
- Travere Therapeutics Inc at Barclays Global Healthcare Conference TranscriptMar 17, 2022
- Q4 2021 Travere Therapeutics Inc Earnings Call TranscriptFeb 24, 2022$27.16 (+4.10%)Earnings
- Travere Therapeutics Inc to Discuss the Topline Results from the Ongoing Phase 1/2 COMPOSE Study of Pegtibatinase in Classical Homocystinuria Call TranscriptDec 15, 2021
- Q3 2021 Travere Therapeutics Inc Earnings Call TranscriptOct 28, 2021$26.59 (+1.49%)Earnings
- Travere Therapeutics Inc Topline Interim Results from the Phase 3 PROTECT Study of Sparsentan in IgA Nephropathy Corporate Call TranscriptAug 16, 2021
- Q2 2021 Travere Therapeutics Inc Earnings Call TranscriptJul 29, 2021$13.84 (-1.77%)Earnings
- Travere Therapeutics Inc to Discuss Regulatory Update on Sparsentan Development Program for Focal Segmental Glomerulosclerosis Call TranscriptMay 25, 2021
- Travere Therapeutics Inc at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 11, 2021
- Q1 2021 Travere Therapeutics Inc Earnings Call TranscriptMay 06, 2021$23.5 (-2.08%)Earnings
- Travere Therapeutics Inc at Barclays Global Healthcare Conference (Virtual) TranscriptMar 10, 2021
- Q4 2020 Travere Therapeutics Inc Earnings Call TranscriptMar 01, 2021$30.56 (-0.84%)Earnings
- Travere Therapeutics, Inc. - Special Call TranscriptFeb 02, 2021
- Travere Therapeutics Inc Corporate Analyst Meeting TranscriptDec 09, 2020
- Q3 2020 Retrophin Inc Earnings Call TranscriptNov 05, 2020$20.88 (-1.69%)Earnings
- Retrophin Inc Announces Agreement to Acquire Orphan Technologies Conference Call TranscriptOct 22, 2020
- Q2 2020 Retrophin Inc Earnings Call TranscriptJul 30, 2020$20.69 (+2.43%)Earnings
- Q1 2020 Retrophin Inc Earnings Call TranscriptMay 11, 2020$16.55 (+8.17%)Earnings
- Retrophin Inc at Barclays Global Healthcare Conference TranscriptMar 11, 2020
- Q4 2019 Retrophin Inc Earnings Call TranscriptFeb 24, 2020$16.56 (-4.17%)Earnings
- Q3 2019 Retrophin Inc Earnings Call TranscriptOct 30, 2019$12 (+4.44%)Earnings
- Retrophin, Inc. - Special Call TranscriptAug 22, 2019
- Q2 2019 Retrophin Inc Earnings Call TranscriptAug 06, 2019$19.24 (+1.96%)Earnings
- Q1 2019 Retrophin Inc Earnings Call TranscriptMay 07, 2019$18.86 (-3.18%)Earnings
- Retrophin Inc at Barclays Global Healthcare Conference TranscriptMar 14, 2019
- Q4 2018 Retrophin Inc Earnings Call TranscriptFeb 26, 2019$21.34 (-0.14%)Earnings
Travere Therapeutics Inc at Bank of America Global Healthcare Conference Transcript
Welcome to the afternoon session of the Bank of America Healthcare Conference. I'm Greg Harrison, one of the biotech analysts here at BofA. And this afternoon, we have Travere Therapeutics with us. Representing Travere is Eric Dube, President and CEO; and Peter Heerma, Chief Commercial Officer. Eric is going to start off with a few preparing remarks and then we'll jump into Q&A.
Great. Well, thank you, Greg, and Bank of America for hosting us. This is an incredibly exciting year for Travere. We have been working on both continuing our commercial presence as well as preparing for what has been early signs of success with approval of FILSPARI in IgA nephropathy as well as completion of several Phase III programs within our pipeline, two of which are with sparsentan, both in FSGS and IgA nephropathy as well as the potential initiation of a Phase III with our pegtibatinase asset later this year in classical homocystinuria
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)